Toggle navigation
Home
Search
Services
Blog
Contact
About
Cloning the Hematopoietic Stem Cell Renewal Factor
Hagen, Frederick S.
Icogenex Corporation, Seattle, WA, United States
Search 22 grants from Frederick Hagen
Search grants from Icogenex Corporation
Share this grant:
:
:
Abstract
Funding
Institution
Comments
Recent in Grantomics:
Ohio State University
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Precision lung cancer therapy design through multiplexed adapter measurement
Glycoprotein Hormone Oligosaccharides
Evasion of Macrophage Lysosomes by L pneumophilia
POG9005 - Dose Intensification of Methotrexate &6-Mercaptourine in Childhood All
Exploiting Novel Device Structures for Deep Ultraviolet Emitters
Recently added grants:
Tumor and Immune Programming of Tumor-Associated Endothelium
Epigenetics of uterine quiescence
Multivalent DNA vaccine-mediated protection against Tuberculosis
Host Genes Critical for Flavivirus Infection
The integrated stress response in stem cells and cancer
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Small Business Innovation Research Grants (SBIR) - Phase I (R43)
Project #
1R43HL055886-01
Application #
2234509
Study Section
Special Emphasis Panel (ZRG7-SSS-3 (22))
Project Start
1996-04-01
Project End
1996-09-30
Budget Start
1996-04-01
Budget End
1996-09-30
Support Year
1
Fiscal Year
1996
Total Cost
Indirect Cost
Institution
Name
Icogenex Corporation
Department
Type
DUNS #
836856351
City
Seattle
State
WA
Country
United States
Zip Code
98103
Comments
Be the first to comment on Frederick Hagen's grant